Clinical Trial Update: A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atezolizumab with chemotherapy in locally advanced or metastatic urothelial bladder cancer has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-04-11